Elizabeth Spence, DO
Family Medicine · Los Angeles, CANPI 1770949596
Payments from drug & device makers
Across 78 payments — averaging $22.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$315
- Lilly USA, LLC$245
- Novo Nordisk$198
- Boehringer Ingelheim$160
- Exact Sciences$125
- Aimmune Therapeutics, Inc.$79
- plus $645 from 19 others
What the payments were for
- Food & beverage$1,768100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 16 | $315 |
| Lilly USA, LLC | 10 | $245 |
| Novo Nordisk | 9 | $198 |
| Boehringer Ingelheim | 7 | $160 |
| Exact Sciences | 6 | $125 |
| Aimmune Therapeutics, Inc. | 3 | $79 |
| GSK | 3 | $77 |
| AstraZeneca | 2 | $49 |
| Gilead | 2 | $48 |
| Idorsia Pharmaceuticals US Inc | 2 | $45 |
| Mayne Pharma Commercial LLC | 2 | $40 |
| Sanofi | 1 | $38 |
| Boston Scientific | 1 | $37 |
| Tandem Diabetes Care, Inc. | 1 | $35 |
| Amgen | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| Merck | 1 | $30 |
| Nestle Healthcare Nutrition Inc. | 1 | $30 |
| AbbVie | 1 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Mannkind Corporation | 1 | $22 |
| IBSA Pharma Inc. | 1 | $21 |
| Tolmar, Inc. | 1 | $16 |
| Madrigal Pharmaceuticals | 1 | $15 |
How this compares
$1,768 in reported general payments places this provider in the 80th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 106 | $1,092 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $660 |
| Losartan Potassium | 40 | $543 |
| Levothyroxine Sodium | 42 | $514 |
| Amlodipine Besylate | 54 | $402 |
| Duloxetine Hcl | 14 | $302 |
| Escitalopram Oxalate | 12 | $201 |
| Gabapentin | 12 | $183 |
| Famotidine | 12 | $183 |
| Quetiapine Fumarate | 28 | $180 |
| Alendronate Sodium | 18 | $148 |
| Omeprazole | 13 | $132 |
| Metformin Hcl | 16 | $115 |
| Lisinopril | 24 | $106 |
| Simvastatin | 13 | $100 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Los Angeles
- Albert NassirLos Angeles$5.7M
- Nader SobhLos Angeles$4.1M
- Alexander RivkinLos Angeles$2.8M
- Pamela KushnerLos Angeles$1.2M
- Scott HowellLos Angeles$793K
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.